AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients

AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients

Botulinum neurotoxin type-A (BoNT-A) blocks the release of acetylcholine from peripheral cholinergic nerve terminals and is an important option for the treatment of disorders characterised by excessive cholinergic neuronal activity. Several BoNT-A products are currently marketed, each with unique ma...

Full description

Bibliographic Details
Main Authors: Malgorzata Field, Andrew Splevins, Philippe Picaut, Marcel van der Schans, Jan Langenberg, Daan Noort, Keith Foster
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Toxins
Subjects:
botulinum toxin
BoNT
spasticity
Dysport<sup>®</sup>, abobotulinumtoxinA
glabellar lines
Online Access:https://www.mdpi.com/2072-6651/10/12/535

Similar Items

Similar Items